NCT03020290 - Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents | Biotech Hunter

Enrollment

335

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

April 10, 2018

Study Completion Date

April 10, 2018

Conditions

Atherosclerosis Obliterans

Interventions

DEVICE

Endovascular treatment for PAD during medical care (SuperA stent (Abbott))

Long femoropopliteal stenting with SuperA devices during medical care. The endovascular treatment for PAD will be done during the usual medical treatment of patient. The intervention is not carried out within the framework of the research protocol

Trial Locations (2)

44093

Nantes CHU, Nantes

85925

CHD Vendée, La Roche-sur-Yon